5:13 PM
 | 
Mar 27, 2013
 |  BC Extra  |  Company News

FDA to review grass allergy tablet

ALK-Abello A/S (CSE:ALK-B) and partner Merck & Co. Inc. (NYSE:MRK) said FDA accepted for review a BLA from Merck...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >